Genetic Technologies Ltd (NASDAQ:GENE)

5.83
Delayed Data
As of Feb 27
 -0.71 / -10.86%
Today’s Change
1.04
Today|||52-Week Range
11.00
+202.78%
Year-to-Date

Today’s Trading

Previous close6.54
Today’s open6.00
Day’s range5.80 - 6.57
Volume2,795,713
Average volume (3 months)4,146,194
Market cap$23.9M
Dividend yield--
Data as of 3:59pm ET, 02/27/2015

Growth & Valuation

Earnings growth (last year)+19.76%
Earnings growth (this year)+22.04%
Earnings growth (next 5 years)--
Revenue growth (last year)+21.38%
P/E ratioNM
Price/Sales4.85
Price/Book13.83

Competitors

 Today’s
change
Today’s
% change
RXIIRxi Pharmaceuticals ...-0.03-2.52%
CBMXCombiMatrix Corp-0.01-0.48%
ICCCImmuCell Corp-0.25-3.62%
WGBSWafergen Biosystems ...+0.40+8.73%
Data as of 3:59pm ET, 02/27/2015

Financials

Next reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$4.2M
Annual profit (last year)-$9.3M
Net profit margin-221.84%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive, Operating &
Financial Officer
Eutillio Buccilli
Scientific Director
Richard Allman
Corporate headquarters
Fitzroy, Victoria (vic)

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account